<SEC-DOCUMENT>0001213900-25-010726.txt : 20250206
<SEC-HEADER>0001213900-25-010726.hdr.sgml : 20250206
<ACCEPTANCE-DATETIME>20250206080016
ACCESSION NUMBER:		0001213900-25-010726
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250206
FILED AS OF DATE:		20250206
DATE AS OF CHANGE:		20250206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTERITY THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001131343
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49843
		FILM NUMBER:		25595507

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		STATE:			C3
		ZIP:			VIC 3000
		BUSINESS PHONE:		61 3 9349 4906

	MAIL ADDRESS:	
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		STATE:			C3
		ZIP:			VIC 3000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRANA BIOTECHNOLOGY LTD
		DATE OF NAME CHANGE:	20010105
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0230141-6k_alterity.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>



<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
6-K</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORT
OF FOREIGN PRIVATE ISSUER</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO RULE 13a-16 OR 15d-163</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the month of February 2025</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Alterity
Therapeutics Limited</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Level 14, 350 Collins Street,
Melbourne, Victoria 3000 Australia</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of Principal Executive Office)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F &#9744;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020040485/ea130838-s8_alteritytherape.htm">333-251073</a>, <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020027969/ea127207-s8_alteritytherap.htm">333-248980</a>
and <a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420418063081/tv508429_s-8.htm">333-228671</a>) and our
Registration Statements on Form F-3 (Files No. <a href="http://www.sec.gov/Archives/edgar/data/1131343/000101376223000033/ea185947-f3_alteritytherape.htm">333-274816</a>, <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020044324/ea132148-f3_alteritytherape.htm">333-251647</a>, <a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420419025615/tv521271_f3.htm">333-231417</a>
and <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020036934/ea129831-f3_alteritytherap.htm">333-250076</a>)</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; border-bottom: Black 2pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALTERITY
THERAPEUTICS LIMITED</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a
development stage enterprise)</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are submitted:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="font-style: normal; vertical-align: top; text-align: justify; background-color: rgb(204,238,255); font-weight: normal">
    <TD STYLE="font-style: normal; width: 9%; text-align: left; font-weight: normal">99.1</TD>
    <TD STYLE="font-style: normal; width: 1%; font-weight: normal"><B>&nbsp;</B></TD>
    <TD STYLE="font-style: normal; text-align: justify; width: 90%; font-weight: normal"><p style="margin-top: 0pt; margin-bottom: 0pt"><A HREF="ea023014101ex99-1_alterity.htm">Trading Halt</A></p></TD></TR>
  </TABLE>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>SIGNATURE</u></b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Alterity Therapeutics Limited</b></font></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif; width: 4%">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif; width: 36%">&nbsp;</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">/s/ Geoffrey P. Kempler</font></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">Geoffrey P. Kempler</font></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">Chairman</font></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-transform: none; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
February 6, 2025</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif">&nbsp;</div></div><!-- Field: /Rule-Page -->



</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea023014101ex99-1_alterity.htm
<DESCRIPTION>TRADING HALT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 14pt; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt">Market Announcement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">6 February 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">Alterity Therapeutics Limited (ASX: ATH) &ndash; Trading Halt</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">Description</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The securities of Alterity Therapeutics Limited (&lsquo;ATH&rsquo;)
will be placed in trading halt at the request of ATH, pending it releasing an announcement. Unless ASX decides otherwise, the securities
will remain in trading halt until the earlier of the commencement of normal trading on Monday, 10 February 2025 or when the announcement
is released to the market.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.05pt">Issued by</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">ASX Compliance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 49%"><B>6 February 2025</B><TD STYLE="width: 2%">&nbsp;</TD>
  <TD STYLE="text-align: right; width: 49%"><B>Market Announcement 1/1</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>ASX Limited</TD>
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: right">ASX Customer Service Centre 131 279 | asx.com.au</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: right"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">6 February 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">By email: melissa.kostopoulos@asx.com.au</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Melissa Kostopoulos</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 210.35pt; margin-bottom: 0pt">Adviser, Listings Compliance (Melbourne) ASX Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 210.35pt 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 210.35pt; margin-bottom: 0pt">Dear Melissa</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 210.35pt 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Request for a trading halt</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE)
(the <B>Company</B>), requests that the Company&rsquo;s securities be placed into a trading halt with immediate effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1pt">For the purposes of Listing Rule 17.1, the Company provides
the following information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">the Company is seeking the trading halt pending an announcement in relation to
a capital raising;</TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in">2.</TD><TD STYLE="text-align: justify">the Company requests that the trading halt continues until the earlier of it making an announcement regarding
the capital raising or until the commencement of trading on Monday 10 February 2025; and</TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in">3.</TD><TD STYLE="text-align: justify">the Company is not aware of any reason why the trading halt should not be granted or of any other information
necessary to inform the market about the trading halt.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 210.35pt; margin-bottom: 0pt">Please contact us should you have any questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 210.35pt 0pt 1.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 210.35pt; margin-bottom: 0pt">Yours sincerely</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 210.35pt 0pt 1.1pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Abby Macnish Niven&nbsp;</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 210.35pt 0pt 1.1pt">Abby Macnish Niven</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 321.25pt; margin-bottom: 0pt">Company Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">For and on behalf of the Board of Alterity Therapeutics Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Alterity Therapeutics Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Level 3, 460 Bourke Street, Melbourne,
VIC 3000 Australia</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>T: +61 (0)3 9349 4906
| WWW.alteritytherapeutics.com</B>&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! "H# 2(  A$! Q$!_\0
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'OA9=7<__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V -T# 2(  A$! Q$!_\0
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MF&V1>8Y .5/^%;TDH33J+0YJSE4IR5&6IY?HGB:]T;4#-O::*1LS1LV=WO\
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M.AP=K#AA[T7=@*/B+X>Z!XIU6'4M3AG>YA01H4F*@ $D<#W)KJ:XWPEXRO\
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MMVM7,D F22(D-@KD8((R#FBBG=@7O#FAQ^'=%BTY)WN&5GDDF< &1W8LS8'
MR2>*;I&A_P!EZIK-[Y_F?VE<+/LVX\O"*F,YY^[FBBBX"C1,>+GU[S_O6(L_
M)V^CE]V?QQBLZ^\,:@FN76K:#K"Z?->HJW<4ML)HY"HPK@9!# <=<'THHHN!
MK7UC>W.B&SAU!8[LQJIN7@5PQ&,DH>,'G(]ZQO#?@W^Q;K4+RXNHGN+XQ[UL
4[<6T2A 0,(">3N.23Z4447 __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
